biotech · Glaucoma · Hepatocellular Carcinoma · AEON
AEON Biopharma
AEON Biopharma is a biotech organization headquartered in irvine, USA. It trades on NYSE under ticker AEON. Primary therapeutic focus areas include Glaucoma, Hepatocellular Carcinoma, Cervical Dystonia, Migraine, Congeni
irvine, USA HQ
11 Employees
Public company Type
AEON · NYSE Ticker
Company details
- Status
- Public
- HQ
- irvine, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 8
- Patents
- 9
Ologen Collagen Matrix
Phase 1 · other · Congenital Glaucoma
Ologen Collagen Matrix for Congenital Glaucoma is a Phase 1 program (other) at AEON Biopharma with 1 ClinicalTrials.gov record(s).
Internal code Trab+Trab+Ologen
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AEON Biopharma
- Phase
- Phase 1
- Modality
- other
- Indication
- Congenital Glaucoma
- Status
- active
- Trials
- 1